☆ 4.3 Editorial Material

Developing an automated robotic factory for novel stem cell therapy production

REGENERATIVE MEDICINE (2016)

Journal

REGENERATIVE MEDICINE

Volume 11, Issue 4, Pages 351-354

Publisher

FUTURE MEDICINE LTD

DOI: 10.2217/rme-2016-0040

Keywords

automation; bioprocessing; bioreactor; cell therapy; mesenchymal stem cells

Categories

Cell & Tissue Engineering Engineering, Biomedical

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Biochemical Research Methods

Umbilical cord derived mesenchymal stromal cells in microcarrier based industrial scale culture sustain the immune regulatory functions

Hikari Kurogi, Atsuko Takahashi, Maya Isogai, Marimu Sakumoto, Takashi Takijiri, Akiko Hori, Tetsuo Furuno, Tetsuo Koike, Tetsumasa Yamada, Tokiko Nagamura-Inoue, Masayo Sakaki-Yumoto

Summary: This study aims to optimize the culture conditions for UC-MSCs using a GMP-compatible serum-free medium and a small-scale bioreactor, later scaled up to a larger volume. UC-MSCs cultured in microcarrier-based bioreactors showed equivalent characteristics to those cultured traditionally in cell culture flasks, meeting the minimum criteria for MSCs. Additionally, the therapeutic effect of microcarrier-based UC-MSCs and conventionally cultured UC-MSCs in immunodeficient mice were found to be equivalent, indicating the potential for mass production of MSCs at an industrial scale.

BIOTECHNOLOGY JOURNAL (2021)

Add to Collection

Article Engineering, Chemical

Development of bioreactor protocols for stem cell-based therapies

Krishna Panchalingam, Tony Wang, Sunghoon Jung, Behnam Ahmadian Baghbaderani

Summary: Stem cell-based therapies offer new treatment options for neurodegenerative disorders, but face challenges in commercialization and widespread application due to the need for high-quality production. The Pharmaceutical Production Research Facility at the University of Calgary has made significant advancements in stem cell bioprocessing, providing technical support for large-scale production of therapeutically-relevant stem cells.

CANADIAN JOURNAL OF CHEMICAL ENGINEERING (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Design and development of a new ambr250® bioreactor vessel for improved cell and gene therapy applications

Marco Rotondi, Ned Grace, John Betts, Neil Bargh, Elena Costariol, Barney Zoro, Christopher J. Hewitt, Alvin W. Nienow, Qasim A. Rafiq

Summary: The emergence of cell and gene therapies has sparked interest, but due to high manufacturing costs and long development times, there is a need for more efficient platforms. By improving the design of the stirred-tank bioreactor, suspension of microcarriers/beads for cell culture has been enhanced, showing promise for future applications in cell therapy and gene therapy.

BIOTECHNOLOGY LETTERS (2021)

Add to Collection

Article Cell Biology

A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors

Giulia Golinelli, Rebecca Talami, Stella Frabetti, Olivia Candini, Giulia Grisendi, Carlotta Spano, Chiara Chiavelli, Gaelle F. Arnaud, Giorgio Mari, Massimo Dominici

Summary: In this study, the dynamic cell-to-cell interactions between tumor and MSCs were investigated using a customized VITVO50 3D bioreactor. The process of tissue colonization and formation of metastatic nodules was recreated under dynamic conditions. The results showed that VITVO50 is an easy handling and versatile bioreactor for developing in vivo-like tumor nodules and investigating dynamic cell-to-cell interactions with MSCs.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Add to Collection

Article Engineering, Biomedical

A scalable culture system incorporating microcarrier for specialised mesenchymal stem cells from human embryonic stem cells

Tingting Gao, Xiyuan Zhao, Jie Hao, Yao Tian, Huike Ma, Wenjing Liu, Bin An, Faguo Sun, Shasha Liu, Baojie Guo, Shuaishuai Niu, Zhongwen Li, Chenxin Wang, Yukai Wang, Guihai Feng, Liu Wang, Wei Li, Jun Wu, Meijin Guo, Qi Zhou, Qi Gu

Summary: In this study, a new microcarrier with hyaluronic acid (HA) as the core material was developed for scalable serum-free suspension culture of hESC-derived MSCs. The optimal microcarriers, with a coating collagen concentration of 100 μg/mL or concave-structured surface (cHAMCs), allowed for the expansion of IMRCs within six days with a high yield. The harvested cells showed high viability, immunomodulatory and regenerative therapeutic promise, as well as increased secretion of extracellular matrix (ECM).

MATERIALS TODAY BIO (2023)

Add to Collection

Review Cell & Tissue Engineering

Advances in automated cell washing and concentration

Anqi Li, Gina D. Kusuma, Dawn Driscoll, Nathan Smith, Dominic M. Wall, Bruce L. Levine, David James, Rebecca Lim

Summary: Successful commercialization of cell therapies requires careful planning and consideration of various factors. Automation plays a crucial role in achieving robust and reproducible manufacturing processes at an industrial scale. Understanding the characteristics and limitations of wash-and-concentrate devices is essential for optimizing cell therapy manufacturing.

CYTOTHERAPY (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

GMP-Compliant Production of Autologous Adipose-Derived Stromal Cells in the NANT 001 Closed Automated Bioreactor

Joan C. Fitzgerald, Niamh Duffy, Giacomo Cattaruzzi, Francesco Vitrani, Alice Paulitti, Flavia Mazzarol, Prisca Mauro, Antonio Sfiligoj, Francesco Curcio, Deirdre M. Jones, Veronica McInerney, Janusz Krawczyk, Jack Kelly, Andrew Finnerty, Katya McDonagh, Una McCabe, Matthew Duggan, Lauren Connolly, Georgina Shaw, Mary Murphy, Frank Barry

Summary: The study validates the utility of the NANT 001 bioreactor for the production of mesenchymal stromal cells (MSCs), showing advantages in automated production of small to medium cell batches and comparable cell yield and viability to manual processing. The automated system can achieve cell standardization, reduce labor input from operators and management personnel.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Add to Collection

Article Cell & Tissue Engineering

A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriers

Robert E. Rogers, Andrew Haskell, Berkley P. White, Sujata Dalal, Megan Lopez, Daniel Tahan, Simin Pan, Gagandeep Kaur, Hyemee Kim, Heather Barreda, Susan L. Woodard, Oscar R. Benavides, Jing Dai, Qingguo Zhao, Kristen C. Maitland, Arum Han, Zivko L. Nikolov, Fei Liu, Ryang Hwa Lee, Carl A. Gregory, Roland Kaunas

Summary: The study introduces a platform for scalable expansion and rapid harvest of ihMSCs using GelMA microcarriers, demonstrating robust immunomodulatory activity. This method offers advantages of reproducibility and low cost, making it a significant contribution to the translational potential of ihMSCs.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Cell Biology

Enhanced chondrogenic differentiation of iPS cell-derived mesenchymal stem/stromal cells via neural crest cell induction for hyaline cartilage repair

Denise Zujur, Ziadoon Al-Akashi, Anna Nakamura, Chengzhu Zhao, Kazuma Takahashi, Shizuka Aritomi, William Theoputra, Daisuke Kamiya, Koichi Nakayama, Makoto Ikeya

Summary: We developed a stepwise differentiation method to generate matrix-rich cartilage spheroids from induced pluripotent stem cell-derived mesenchymal stem/stromal cells (iMSCs) via the induction of neural crest cells under xeno-free conditions. By using a thienoindazole derivative, TD-198946, we achieved enhanced chondrogenesis in iMSCs. Our findings provide a novel cell source for stem cell-based cartilage repair and offer the potential for biofabrication of larger cartilage tissues using chondrogenic spheroids and technologies such as Kenzan Bioprinting.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all

Blazej Nowak, Piotr Rogujski, Miroslaw Janowski, Barbara Lukomska, Anna Andrzejewska

Summary: Mesenchymal stem cells (MSCs) show potential in the treatment of glioblastoma (GBM), with possibilities of anti-tumor properties as well as risks of increasing tumor aggressiveness.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Add to Collection

Article Medicine, Research & Experimental

Hypoxic ucMSC-secreted exosomal miR-125b promotes endothelial cell survival and migration during wound healing by targeting TP53INP1

Xiao-Fei Zhang, Ting Wang, Zi-Xuan Wang, Kun-Peng Huang, Yun-Wei Zhang, Guo-Liang Wang, Hong-Ji Zhang, Zi-Han Chen, Chang-Yan Wang, Jin-Xiang Zhang, Hui Wang

Summary: In a hypoxic microenvironment, ucMSCs enhance endothelial cell proliferation and migration through exosome-mediated paracrine function, accelerating wound healing. miR-125b in hypoxic exosomes targets and suppresses TP53INP1, alleviating hypoxia-induced cell apoptosis and promoting cutaneous repair.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Add to Collection

Article Cell & Tissue Engineering

Gap junction-mediated cell-cell interaction between transplanted mesenchymal stem cells and vascular endothelium in stroke

Akie Kikuchi-Taura, Yuka Okinaka, Orie Saino, Yukiko Takeuchi, Yuko Ogawa, Takafumi Kimura, Sheraz Gul, Carsten Claussen, Johannes Boltze, Akihiko Taguchi

Summary: The study revealed that mesenchymal stem cells can suppress inflammation in the brain through cell-cell interaction, potentially offering a new strategy to maintain the blood-brain barrier in injured brain. This finding may provide new insights for clinical trials using MSC transplantation to suppress excess inflammation, including in diseases like COVID-19.

STEM CELLS (2021)

Add to Collection

Article Cell & Tissue Engineering

Production of Mesenchymal Progenitor Cell-Derived Extracellular Vesicles in Suspension Bioreactors for Use in Articular Cartilage Repair

Jolene Phelps, Catherine Leonard, Sophia Shah, Roman Krawetz, David A. Hart, Neil A. Duncan, Arindom Sen

Summary: Mesenchymal progenitor cells (MPCs) have shown promise in initiating articular cartilage repair, largely due to the trophic factors they secrete. This study found that these factors can be found in the conditioned medium (CM) collected from cell cultures, with extracellular vesicles (EVs) believed to play a role in MPC therapeutic efficacy. The study also found that clinically relevant quantities of MPC-derived EVs can be generated using stirred suspension bioreactors (SSBs), which could potentially induce cartilage repair.

STEM CELLS TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Immunology

Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing via Mechanotransduction

Max A. Skibber, Scott D. Olson, Karthik S. Prabhakara, Brijesh S. Gill, Charles S. Cox

Summary: Mechanotransduction, achieved by exposing MSC to various grades of wall shear stress (WSS), enhances their immunomodulatory potential independent of classical pro-inflammatory cytokines. The study suggests biomechanical conditioning as a viable and scalable pre-conditioning alternative to enhance the immunomodulatory capacity of MSC in cell therapy manufacturing.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

A modular 3D printed microfluidic system: a potential solution for continuous cell harvesting in large-scale bioprocessing

Lin Ding, Sajad Razavi Bazaz, Mahsa Asadniaye Fardjahromi, Flyn McKinnirey, Brian Saputro, Balarka Banerjee, Graham Vesey, Majid Ebrahimi Warkiani

Summary: Microfluidic devices have great potential in the bioprocessing industry, but the lack of modularity and the high cost of testing and error limit their implementation. Advances in 3D printing technologies have made it possible to convert microfluidic devices from research output to applicable industrial systems.

BIORESOURCES AND BIOPROCESSING (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Development of a process control strategy for the serum-free microcarrier expansion of human mesenchymal stem cells towards cost-effective and commercially viable manufacturing

Thomas R. J. Heathman, Alvin W. Nienow, Qasim A. Rafiq, Karen Coopman, Bo Kara, Christopher J. Hewitt

BIOCHEMICAL ENGINEERING JOURNAL (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

A scaled-down model for the translation of bacteriophage culture to manufacturing scale

Junaid Ali, Qasim Rafiq, Elizabeth Ratcliffe

BIOTECHNOLOGY AND BIOENGINEERING (2019)

Add to Collection

Article Cell & Tissue Engineering

Beta-tricalcium phosphate ceramic triggers fast and robust bone formation by human mesenchymal stem cells

Rui C. Pereira, Roberto Benelli, Barbara Canciani, Monica Scaranari, Guy Daculsi, Ranieri Cancedda, Chiara Gentili

JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

CAR-T immunotherapies: Biotechnological strategies to improve safety, efficacy and clinical outcome through CAR engineering

Theano I. Panagopoulou, Qasim A. Rafiq

BIOTECHNOLOGY ADVANCES (2019)

Add to Collection

Article Cell Biology

Progenitor Cells Activated by Platelet Lysate in Human Articular Cartilage as a Tool for Future Cartilage Engineering and Reparative Strategies

Simonetta Carluccio, Daniela Martinelli, Maria Elisabetta Federica Palama, Rui Cruz Pereira, Roberto Benelli, Ana Guijarro, Ranieri Cancedda, Chiara Gentili

CELLS (2020)

Add to Collection

Article Biochemical Research Methods

Demonstrating the Manufacture of Human CAR-T Cells in an Automated Stirred-Tank Bioreactor

Elena Costariol, Marco C. Rotondi, Arman Amini, Christopher J. Hewitt, Alvin W. Nienow, Thomas R. J. Heathman, Qasim A. Rafiq

BIOTECHNOLOGY JOURNAL (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Expansion of human mesenchymal stem/stromal cells (hMSCs) in bioreactors using microcarriers: lessons learnt and what the future holds

P. Silva Couto, M. C. Rotondi, A. Bersenev, C. J. Hewitt, A. W. Nienow, F. Verter, Q. A. Rafiq

BIOTECHNOLOGY ADVANCES (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Design and development of a new ambr250® bioreactor vessel for improved cell and gene therapy applications

Marco Rotondi, Ned Grace, John Betts, Neil Bargh, Elena Costariol, Barney Zoro, Christopher J. Hewitt, Alvin W. Nienow, Qasim A. Rafiq

Summary: The emergence of cell and gene therapies has sparked interest, but due to high manufacturing costs and long development times, there is a need for more efficient platforms. By improving the design of the stirred-tank bioreactor, suspension of microcarriers/beads for cell culture has been enhanced, showing promise for future applications in cell therapy and gene therapy.

BIOTECHNOLOGY LETTERS (2021)

Add to Collection

Article Cell & Tissue Engineering

Role of extracellular vesicles from adipose tissue- and bone marrow-mesenchymal stromal cells in endothelial proliferation and chondrogenesis

Cansu Gorgun, Maria Elisabetta Federica Palama, Daniele Reverberi, Maria Cristina Gagliani, Katia Cortese, Roberta Tasso, Chiara Gentili

Summary: The secretome of mesenchymal stromal cells (MSCs) derived from different tissue sources is considered an innovative therapeutic tool for regenerative medicine. The study compared middle- and small-sized extracellular vesicles (EVs) released by adipose tissue-derived MSCs (ADSCs) and bone marrow-derived MSCs (BMSCs), showing different protein content and functional effects, with ADSC-EVs overexpressing pro-angiogenic factors and BMSC-EVs containing a higher amount of pro-differentiation and chemotactic proteins. This study highlights the importance of selecting the appropriate cell source of EVs for targeted therapeutic applications.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Needle to needle robot-assisted manufacture of cell therapy products

Jelena Ochs, Mariana P. Hanga, Georgina Shaw, Niamh Duffy, Michael Kulik, Nokilaj Tissin, Daniel Reibert, Ferdinand Biermann, Panagiota Moutsatsou, Shibani Ratnayake, Alvin Nienow, Niels Koenig, Robert Schmitt, Qasim Rafiq, Christopher J. Hewitt, Frank Barry, J. Mary Murphy

Summary: Advanced therapeutic medicinal products (ATMPs) have created a demand for large volumes of high-quality GMP cells. This study presents a fully automated, robot-assisted platform for scalable production of adherent human stem cells. The platform allows for a closed process from bone marrow collection to cell isolation, expansion, and collection into cryovials for patient delivery.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Cell Biology

Regenerative and Anti-Inflammatory Potential of Regularly Fed, Starved Cells and Extracellular Vesicles In Vivo

Federico Ferro, Renza Spelat, Georgina Shaw, Cynthia M. Coleman, Xi Zhe Chen, David Connolly, Elisabetta M. F. Palama, Chiara Gentili, Paolo Contessotto, Mary J. Murphy

Summary: This study evaluated the anti-inflammatory and regenerative effects of bone marrow MSC and their extracellular vesicles in a diabetic fractured mouse model. The results showed that preconditioned cells promoted earlier soft callus formation and mineralization at the fracture site, suggesting the importance of preconditioning in MSC therapy research and optimization.

CELLS (2022)

Add to Collection

Article Cell Biology

Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Carlo Genova, Roberta Tasso, Alessandra Rosa, Giovanni Rossi, Daniele Reverberi, Vincenzo Fontana, Silvia Marconi, Michela Croce, Maria Giovanna Dal Bello, Chiara Dellepiane, Marco Tagliamento, Maria Chiara Ciferri, Lodovica Zullo, Alessandro Fedeli, Angela Alama, Katia Cortese, Chiara Gentili, Eugenia Cella, Giorgia Anselmi, Marco Mora, Giulia Barletta, Erika Rijavec, Francesco Grossi, Paolo Pronzato, Simona Coco

Summary: The advent of immune checkpoint inhibitors (ICIs) has dramatically changed the treatment of non-small cell lung cancer (NSCLC). However, their efficacy remains limited to a subset of patients. This study evaluated the prognostic role of soluble (s) immune checkpoints and immune checkpoints associated with extracellular vesicles (EVs) in NSCLC patients treated with ICIs. The results showed that high levels of sPD-L1, sB7-H3, and sB7-H4 were associated with different prognoses in advanced NSCLC patients treated with ICIs. The study also suggested potential involvement of EVs in the disease response to ICIs.

CELLS (2023)

Add to Collection

Article Biotechnology & Applied Microbiology

Scalable manufacturing of gene-modified human mesenchymal stromal cells with microcarriers in spinner flasks

Pedro Silva Couto, Dale J. J. Stibbs, Marco C. C. Rotondi, Yasuhiro Takeuchi, Qasim A. A. Rafiq

Summary: This study demonstrates a scalable manufacturing process using a microcarrier-bioreactor system for the expansion of gene-modified human mesenchymal stromal cells (hMSCs). The transduced and expanded cells met the criteria established by the International Society for Cell and Gene Therapy (ISCT). This work provides a foundation for the scalable manufacturing of gene-modified hMSCs.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2023)

Add to Collection

Article Medicine, Research & Experimental

Optimizing and developing a scalable, chemically defined, animal component-free lentiviral vector production process in a fixed-bed bioreactor

Carme Ripoll Fiol, Marie-Laure Collignon, John Welsh, Qasim A. Rafiq

Summary: This study optimized and developed a scalable, chemically defined, animal component-free LVV production process using adherent human embryonic kidney 293T cells in a fixed-bed bioreactor. By changing the process conditions, such as reducing cell seeding density, delaying transient transfection, reducing plasmid DNA dosage, and adding compound, the LVV titer was improved by 26.9-fold. The results showed comparable LVV titers with traditional culture methods at different scales.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2023)

Add to Collection

Article Dermatology

Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients

Giulia Gasparini, Roberta Tasso, Maria Elisabetta Federica Palama, Maria Chiara Ciferri, Chiara Gentili, Giovanni Di Zenzo, Alessia Provini, Adele Salemme, Rodolfo Quarto, Aurora Parodi, Emanuele Cozzani

Summary: This study aimed to investigate the presence of BP targeted autoantigens in blister fluid-derived extracellular vesicles (EVs). EVs were isolated from blister fluid of BP patients and suction blister fluid of healthy donors, and EV characterization was performed. Western blot analysis revealed the presence of BP180 in EVs derived from blister fluid of 3 out of 6 BP patients, while no BP180 was detected in EVs from healthy donors. This discovery provides insights into the pathogenesis of BP.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.